Lars Ångman

This profile gathers the share dealings of Lars Ångman in MedCap AB (publ). In total, 8 filings cover trades dated from 9 December 2021 to 4 December 2024.

Market trades split into 4 purchases (€81k) and 1 sale (€1.4M). Netting one side against the other leaves €1.3M of net selling. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Since January 2024: no purchases and 1 sale on the market.

Half of the purchases are above €23k and half below. Across 4 purchases, this insider has always bought alone, with no colleague buying within 30 days. For 4 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 0% of cases, with a median move of -0.1%. They describe history only and say nothing certain about the share price ahead.

The latest filing, published on 4 December 2024, reports a transaction in MedCap AB (publ). The last purchase on record was published on 13 December 2021, which is 1,773 days ago. Half of the filings or more reach the Finansinspektionen feed on the day of the trade. The regulation allows three business days to notify a trade (MAR article 19). These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.